Intravenous glycoprotein IIbIIIa inhibitor bridging for urgent coronary artery bypass graft after acute coronary syndrome

Back

ESC Premium Access

Intravenous glycoprotein IIbIIIa inhibitor bridging for urgent coronary artery bypass graft after acute coronary syndrome

Session: Pharmacology and Pharmacotherapy ePosters

Topic: Antiplatelet Drugs

Speaker: Doctor M. Reis (Sao Paulo, BR)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Mayara Reis

Instituto do Coracao FMUSP, Sao Paulo (Brazil)

0 follower

56 more presentations in this session

Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects

Speaker: Professor Y. Huo (Beijing, CN)

Access

Abstract

Slides

Vericiguat clinical pharmacology programme: biopharmaceutical properties and potential intrinsic and extrinsic factor effects

Speaker: Doctor C. Becker (Wuppertal, DE)

Access

Abstract

Slides

Physiologically-based pharmacokinetic (PBPK) exploration of extrinsic factors influencing vericiguat pharmacokinetics

Speaker: Doctor S. Frechen (Leverkusen, DE)

Access

Abstract

Slides

Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study

Speaker: Doctor C. Ballantyne (Houston, US)

Access

Abstract

Slides

The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population

Speaker: Doctor D. Radenkovic (Greater London, GB)

Access

Abstract

Slides

Access the full session

Pharmacology and Pharmacotherapy ePosters

Speakers: Doctor M. Reis, Professor Y. Huo, Doctor C. Becker, Doctor S. Frechen, Doctor C. Ballantyne...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources